Phreesia (PHR) Stock Overview
Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PHR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Phreesia, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$30.80 |
| 52 Week High | US$31.46 |
| 52 Week Low | US$17.07 |
| Beta | 0.71 |
| 1 Month Change | 15.66% |
| 3 Month Change | 32.19% |
| 1 Year Change | 21.64% |
| 3 Year Change | 29.63% |
| 5 Year Change | -3.51% |
| Change since IPO | 22.81% |
Recent News & Updates
Recent updates
Why Phreesia Feels Like The Right Bet In Healthcare Tech
Aug 18
Digital Healthcare Tools Will Expand Market Reach
Expanding digital adoption and data-driven solutions are driving operational efficiency, deeper client relationships, and long-term recurring revenue growth.Revenues Tell The Story For Phreesia, Inc. (NYSE:PHR)
Apr 29
Why Phreesia, Inc. (NYSE:PHR) Could Be Worth Watching
Mar 07Phreesia (NYSE:PHR) Has Debt But No Earnings; Should You Worry?
Feb 14Phreesia, Inc.'s (NYSE:PHR) Shares Climb 27% But Its Business Is Yet to Catch Up
Dec 27Phreesia Has Turned The Corner, Can It Continue To Mend?
Dec 12Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues
Nov 07Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?
Oct 08Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results
Sep 06Phreesia: Remain Bullish Given The Healthy Growth Outlook
Sep 05Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher
Jul 18Phreesia: Growth Remains Strong, With EBITDA Margin Set To Improve
Jun 06The Price Is Right For Phreesia, Inc. (NYSE:PHR)
May 25Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?
May 03At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Apr 12Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)
Feb 16Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth
Jan 04Is Phreesia Finally Turning The Corner?
Dec 07Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?
Oct 25Phreesia: Share Price Dip Is A Buying Opportunity
Sep 21Phreesia: Strong Execution Should Continue To Drive Growth
Jul 11Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion
May 18Phreesia: Strong Growth Momentum With Expanded TAM
Jan 28Phreesia - Healthcare Ecosystem At An Attractive Valuation
Dec 13Shareholder Returns
| PHR | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 9.0% | 2.0% | 1.3% |
| 1Y | 21.6% | 25.1% | 16.2% |
Return vs Industry: PHR underperformed the US Healthcare Services industry which returned 24.1% over the past year.
Return vs Market: PHR exceeded the US Market which returned 15.5% over the past year.
Price Volatility
| PHR volatility | |
|---|---|
| PHR Average Weekly Movement | 5.8% |
| Healthcare Services Industry Average Movement | 9.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PHR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: PHR's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 2,082 | Chaim Indig | www.phreesia.com |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients’ mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks.
Phreesia, Inc. Fundamentals Summary
| PHR fundamental statistics | |
|---|---|
| Market cap | US$1.81b |
| Earnings (TTM) | -US$42.72m |
| Revenue (TTM) | US$434.53m |
Is PHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHR income statement (TTM) | |
|---|---|
| Revenue | US$434.53m |
| Cost of Revenue | US$138.98m |
| Gross Profit | US$295.55m |
| Other Expenses | US$338.27m |
| Earnings | -US$42.72m |
Last Reported Earnings
Apr 30, 2025
Next Earnings Date
Sep 04, 2025
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 68.02% |
| Net Profit Margin | -9.83% |
| Debt/Equity Ratio | 0.6% |
How did PHR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/26 10:53 |
| End of Day Share Price | 2025/08/26 00:00 |
| Earnings | 2025/04/30 |
| Annual Earnings | 2025/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Phreesia, Inc. is covered by 21 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Zhilin Long | Berenberg |
| Richard Close | Canaccord Genuity |